Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: €0.01 M
• Last 3 months FTD volume: €0.66 M
• Last 12 months FTD volume: €4.47 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	€56.21 M	€0.12 B	🇺🇸 USA
Merck MRK	€36.21 M	€0.14 B	🇺🇸 USA
GSK plc GSK	€48.95 M	€0.36 B	🇬🇧 UK
Soligenix SNGX	€0.46 M	€14.16 M	🇺🇸 USA
SIGA Technologies SIGA	€0.11 M	€1.07 M	🇺🇸 USA
Celldex Therapeutics CLDX	€6.56 M	€10.98 M	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	€53.08 M	€87.14 M	🇮🇱 Israel